About HENGRUI PHARMA Company

Founded in 1970, the company was listed on the Shanghai Stock Exchange in 2000 and on the Hong Kong Stock Exchange in 2025, becoming a dual‑A+H‑listed enterprise. As an innovative, globally oriented pharmaceutical company dedicated to the research, development, manufacturing, and marketing of high‑quality medicines, it remains steadfastly committed to its patient‑centered mission. The company focuses on oncology, metabolic and cardiovascular diseases, immune and respiratory disorders, and neuroscience, continuously advancing drug discovery to conquer disease, enhance quality of life, and extend lifespan. By expanding the frontiers of what is possible, it harnesses the power of science and technology to benefit patients worldwide. The company's core business encompasses the R&D, production, and commercialization of pharmaceutical products. Its key offerings include Pyrrotinib Maleate Tablets, Camrelizumab for Injection, Rivirumab Tablets, Haqubopa Ethanolamide Tablets, Darzalex Hydroxyethylsulfonate Tablets, and Iodixanol Injection, among others. In recognition of its environmental and quality‑management achievements, the company has been honored as an "Environmental Demonstration Enterprise" and a "Green Development Leader" in Jiangsu Province. In 2023, it received the "Environmental Protection Quality Award" from the Lianyungang Economic and Technological Development Zone, was named one of the "First Batch of Sterile Drug Quality Assurance Enterprises" by the China Association for Pharmaceutical Quality Management, and was awarded the title of "Outstanding Pharmaceutical Quality Management Enterprise in Jiangsu Province" by the Jiangsu Provincial Pharmaceutical Quality Management Association. Additionally, the company's "Chuying QC Group" and "Yuanzhi QC Group" were recognized as exemplary quality‑control (QC) teams in the Jiangsu pharmaceutical industry, earning accolades such as the "Green Development Leader" award, top presentation honors, and first‑class and excellence awards from national, provincial, and municipal quality‑assurance associations.